Paul Campanelli - Net Worth and Insider Trading
Paul Campanelli Net Worth
The estimated net worth of Paul Campanelli is at least $128 dollars as of 2024-11-13. Paul Campanelli is the President, CEO of Endo International PLC and owns about 213,620 shares of Endo International PLC (ENDPQ) stock worth over $128. Details can be seen in Paul Campanelli's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Campanelli has not made any transactions after 2017-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Campanelli
Paul Campanelli Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Campanelli owns 2 companies in total, including Endo International PLC (ENDPQ) , and Convey Health Solutions Holdings Inc (CNVY) .
Click here to see the complete history of Paul Campanelli’s form 4 insider trades.
Insider Ownership Summary of Paul Campanelli
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ENDPQ | Endo International PLC | 2017-08-14 | Group President & Generics |
CNVY | Convey Health Solutions Holdings Inc | 2022-10-07 | director |
Paul Campanelli Latest Holdings Summary
Paul Campanelli currently owns a total of 1 stock. Paul Campanelli owns 213,620 shares of Endo International PLC (ENDPQ) as of August 14, 2017, with a value of $128.
Latest Holdings of Paul Campanelli
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ENDPQ | Endo International PLC | 2017-08-14 | 213,620 | 0.00 | 128 |
Holding Weightings of Paul Campanelli
Paul Campanelli Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Campanelli has made a total of 0 transactions in Endo International PLC (ENDPQ) over the past 5 years. The most-recent trade in Endo International PLC is the acquisition of 6,500 shares on August 14, 2017, which cost Paul Campanelli around $50,115.
Insider Trading History of Paul Campanelli
- 1
Paul Campanelli Trading Performance
GuruFocus tracks the stock performance after each of Paul Campanelli's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Campanelli is 5.55%. GuruFocus also compares Paul Campanelli's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Campanelli within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul Campanelli's insider trading performs compared to the benchmark.
Performance of Paul Campanelli
Paul Campanelli Ownership Network
Ownership Network List of Paul Campanelli
Ownership Network Relation of Paul Campanelli
Paul Campanelli Owned Company Details
What does Endo International PLC do?
Who are the key executives at Endo International PLC?
Paul Campanelli is the Group President & Generics of Endo International PLC. Other key executives at Endo International PLC include Executive VP & Global R&D James Patrick Tursi , VP & Controller and CAO Frank B. Raciti , and EVP & Head of Global R&D George Apostol .
Endo International PLC (ENDPQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Endo International PLC (ENDPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endo International PLC (ENDPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Endo International PLC (ENDPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Endo International PLC Insider Transactions
Paul Campanelli Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Campanelli. You might contact Paul Campanelli via mailing address: C/o Par Pharmaceutical Companies, Inc., One Ram Ridge Road, Chestnut Ridge Ny 10977.